| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
3,686 |
2,854 |
$185K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,322 |
2,400 |
$183K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
219 |
215 |
$81K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,576 |
2,410 |
$71K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,582 |
2,408 |
$71K |
| 80050 |
General health panel |
1,387 |
1,341 |
$54K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
822 |
786 |
$54K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
2,482 |
2,335 |
$53K |
| 80061 |
Lipid panel |
5,057 |
4,837 |
$52K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
10,635 |
8,641 |
$51K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
1,578 |
1,502 |
$51K |
| 80053 |
Comprehensive metabolic panel |
8,331 |
7,470 |
$49K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,095 |
3,874 |
$44K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,874 |
4,611 |
$35K |
| 80356 |
|
2,076 |
1,927 |
$31K |
| 80361 |
|
2,082 |
1,925 |
$28K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
1,065 |
1,040 |
$26K |
| 80348 |
|
2,107 |
1,941 |
$25K |
| 80354 |
|
2,099 |
1,941 |
$25K |
| 80346 |
|
2,019 |
1,861 |
$24K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,709 |
3,432 |
$22K |
| 86780 |
|
1,682 |
1,660 |
$22K |
| 80358 |
|
1,953 |
1,808 |
$21K |
| 80325 |
|
2,019 |
1,863 |
$20K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,306 |
1,188 |
$20K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,998 |
1,521 |
$20K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
590 |
568 |
$19K |
| 80365 |
|
2,057 |
1,914 |
$19K |
| 80372 |
|
2,067 |
1,923 |
$18K |
| 80353 |
|
1,982 |
1,829 |
$18K |
| 84439 |
|
2,199 |
2,140 |
$17K |
| 80357 |
|
1,984 |
1,833 |
$17K |
| 80360 |
|
2,010 |
1,862 |
$17K |
| 80359 |
|
1,992 |
1,844 |
$17K |
| 80369 |
|
1,940 |
1,808 |
$16K |
| 80373 |
|
2,048 |
1,906 |
$16K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
402 |
383 |
$14K |
| 80362 |
|
1,138 |
1,049 |
$14K |
| 87070 |
|
1,753 |
1,686 |
$14K |
| 83655 |
|
1,070 |
1,045 |
$13K |
| 80349 |
|
1,185 |
1,093 |
$11K |
| 87581 |
|
241 |
235 |
$10K |
| 87486 |
|
242 |
236 |
$10K |
| 86803 |
|
1,078 |
974 |
$10K |
| 87186 |
|
1,518 |
1,423 |
$10K |
| 87077 |
|
1,565 |
1,468 |
$9K |
| 84146 |
|
496 |
470 |
$9K |
| 88141 |
|
381 |
366 |
$9K |
| 80164 |
|
874 |
819 |
$9K |
| 82607 |
|
949 |
909 |
$9K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,399 |
1,970 |
$8K |
| 87081 |
|
1,254 |
1,222 |
$8K |
| 80074 |
|
184 |
178 |
$8K |
| 83992 |
|
1,933 |
1,801 |
$8K |
| 80363 |
|
885 |
833 |
$7K |
| 84481 |
|
478 |
468 |
$7K |
| 87340 |
|
724 |
692 |
$7K |
| 83880 |
|
372 |
330 |
$6K |
| 87400 |
|
284 |
282 |
$6K |
| 86696 |
|
279 |
276 |
$5K |
| 86762 |
|
379 |
376 |
$5K |
| 88142 |
|
277 |
264 |
$5K |
| 82140 |
|
366 |
233 |
$4K |
| 82728 |
|
412 |
390 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
2,431 |
2,177 |
$4K |
| 86235 |
|
106 |
100 |
$4K |
| 80351 |
|
194 |
177 |
$4K |
| 85027 |
|
778 |
744 |
$4K |
| 84134 |
|
309 |
292 |
$4K |
| 85610 |
|
1,959 |
765 |
$3K |
| 86003 |
|
56 |
55 |
$3K |
| 84403 |
|
168 |
151 |
$3K |
| 86850 |
|
449 |
442 |
$3K |
| 80177 |
|
307 |
290 |
$3K |
| 84702 |
|
243 |
188 |
$3K |
| 87522 |
Neg quan hep c or qual rna |
285 |
232 |
$3K |
| 86695 |
|
220 |
218 |
$3K |
| 84436 |
|
541 |
504 |
$3K |
| 82746 |
|
290 |
278 |
$3K |
| 80076 |
|
645 |
613 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
191 |
187 |
$3K |
| 80178 |
|
384 |
353 |
$2K |
| 87075 |
|
311 |
293 |
$2K |
| 86757 |
|
64 |
62 |
$2K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
103 |
103 |
$2K |
| 83540 |
|
458 |
441 |
$2K |
| 81001 |
|
1,332 |
1,225 |
$2K |
| 84703 |
|
281 |
259 |
$2K |
| 83550 |
|
308 |
293 |
$2K |
| 82128 |
|
206 |
198 |
$2K |
| 82261 |
|
206 |
198 |
$2K |
| 82760 |
|
206 |
198 |
$2K |
| 82725 |
|
204 |
197 |
$2K |
| 83919 |
|
202 |
194 |
$2K |
| 84153 |
|
178 |
160 |
$2K |
| 87147 |
|
390 |
378 |
$2K |
| 82950 |
|
411 |
405 |
$2K |
| 86706 |
|
194 |
186 |
$2K |
| 85013 |
|
356 |
344 |
$2K |
| 86038 |
|
162 |
161 |
$2K |
| 87493 |
|
65 |
59 |
$2K |
| 86704 |
|
166 |
157 |
$2K |
| 83735 |
|
427 |
371 |
$2K |
| 87481 |
|
63 |
54 |
$1K |
| 83516 |
|
84 |
80 |
$1K |
| 81003 |
|
959 |
918 |
$1K |
| 86140 |
|
356 |
306 |
$1K |
| 87511 |
|
62 |
53 |
$1K |
| 84550 |
|
455 |
425 |
$1K |
| 86665 |
|
48 |
48 |
$1K |
| 86901 |
|
386 |
380 |
$1K |
| 86900 |
|
388 |
382 |
$1K |
| 80185 |
|
202 |
166 |
$1K |
| 87046 |
|
156 |
94 |
$1K |
| 86225 |
|
118 |
110 |
$1K |
| 82947 |
|
299 |
293 |
$1K |
| 84030 |
|
201 |
193 |
$1K |
| 86618 |
|
60 |
58 |
$917.38 |
| 82977 |
|
1,116 |
878 |
$886.85 |
| 87045 |
|
97 |
92 |
$837.38 |
| 86480 |
|
36 |
26 |
$827.07 |
| 86709 |
|
121 |
102 |
$752.31 |
| 82785 |
|
45 |
45 |
$736.45 |
| 82570 |
|
195 |
188 |
$735.83 |
| 86664 |
|
45 |
45 |
$700.32 |
| 83001 |
|
40 |
38 |
$686.39 |
| 85652 |
|
339 |
305 |
$679.39 |
| 86666 |
|
56 |
54 |
$653.45 |
| 87427 |
|
62 |
44 |
$637.85 |
| 86663 |
|
46 |
46 |
$619.55 |
| 84144 |
|
27 |
26 |
$550.20 |
| 83020 |
|
180 |
174 |
$518.43 |
| 82670 |
|
28 |
26 |
$515.45 |
| 83970 |
|
28 |
28 |
$510.50 |
| 87530 |
|
12 |
12 |
$454.91 |
| 86708 |
|
50 |
44 |
$338.77 |
| 84479 |
|
64 |
63 |
$336.43 |
| P9603 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled |
5,221 |
3,525 |
$331.63 |
| 83525 |
|
30 |
30 |
$320.70 |
| 83690 |
|
58 |
57 |
$315.14 |
| 82043 |
|
77 |
77 |
$267.41 |
| 86308 |
|
50 |
48 |
$249.98 |
| 82274 |
|
38 |
33 |
$219.68 |
| G0471 |
Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) |
5,455 |
3,644 |
$212.53 |
| 82550 |
|
41 |
38 |
$186.23 |
| 36416 |
|
62 |
55 |
$179.66 |
| 80156 |
|
15 |
15 |
$175.02 |
| 80162 |
|
27 |
25 |
$164.43 |
| 82951 |
|
15 |
15 |
$160.30 |
| 86376 |
|
12 |
12 |
$157.96 |
| 86431 |
|
40 |
40 |
$152.39 |
| 82150 |
|
32 |
31 |
$143.52 |
| 80069 |
|
54 |
52 |
$122.57 |
| 83615 |
|
15 |
13 |
$72.82 |
| 86689 |
|
15 |
12 |
$71.70 |
| 82952 |
|
15 |
15 |
$55.76 |
| 80374 |
|
14 |
13 |
$45.92 |
| 84132 |
|
37 |
28 |
$41.98 |
| 84156 |
|
13 |
12 |
$35.09 |
| 80366 |
|
13 |
12 |
$22.96 |
| 99082 |
|
190 |
128 |
$1.20 |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
189 |
143 |
$1.14 |
| 87536 |
|
14 |
13 |
$0.00 |
| 80324 |
|
17 |
14 |
$0.00 |